Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Acute effects of antiarrhythmic drugs on stable ventricular premature beats

Controlled comparison of lorcainide and lidocaine

  • 14 Accesses

  • 3 Citations


Nineteen patients with refractory but stable ventricular premature beats (VPB) received 3 medications intravenously at 24-h intervals. Lorcainide (2 mg/kg) and placebo were given double-blind in randomized sequence and the third treatment was 100 mg lidocaine, the standard reference drug. Continuous ECG recordings were made for the first 2 hours after administration to study the antiarrhythmic effect; the stability of the arrhythmia, the absence of residual and of period effects, and the interdrug differences in efficacy were statistically evaluated. Lorcainide significantly reduced the frequency of VPB during the 2-hour period, whereas the effect of lidocaine was more short-lived. The median individual peak reduction in VPB was 96% for lorcainide and 47% for lidocaine. No significant reduction in VPB was observed with placebo. Adverse effects were acceptable with either active treatment.

This is a preview of subscription content, log in to check access.


  1. 1.

    Amery WK, Heykants JJP, Xhonneux R, Towse G, Oettel P, Gough DA, Janssen PAJ (1981) Lorcainide (R 15 889), a first review. Acta Cardiol 36: 207–234

  2. 2.

    Gaughan CE, Lown B, Lanigan J, Voukydis P, Besser W (1976) Acute oral testing for determining antiarrhythmic drug efficacy. I. Quinidine. Am J Cardiol 38: 677–684

  3. 3.

    Klein G, Wirtzfeld A, Schlegel J, Himmler Ch, Neiss A (1980) Antiarrhythmika bei chronischer ventrikulärer Extrasystolie. Vergleichende Untersuchung zur Wirksamkeit von Lidocain, Ajmalin, Propafenon und Org 6001. Dtsch Med Wochenschr 105: 189–194

  4. 4.

    Siegel S (1956) Nonparametric statistics. McGraw-Hill, New York, pp 166–172

  5. 5.

    Koch GG (1972) The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics 28: 577–584

  6. 6.

    Smith WS, Vismara L, Kalmansohn RB, Jutzy RV, Cook WR, Pugh DM, Berman R, Laidlaw JC, Oshrain C, Dreifus LS, Nisbet J (1975) Clinical studies of norpace. Angiology 26 [Suppl 1]: 124–149

  7. 7.

    Morganroth J, Michelson EL, Horowitz LN, Josephson ME, Pearlman AS, Dunkman WB (1978) Limitations of routine long-term ambulatory electrocardiographic monitoring to assess ventricular ectopic frequency. Circulation 58: 408–414

  8. 8.

    Dreifus LS, Morganroth J (1980) Antiarrhythmic agents and their use in therapy. Pharmac Ther 9: 75–106

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Schmidt, G., Klein, G. & Wirtzfeld, A. Acute effects of antiarrhythmic drugs on stable ventricular premature beats. Eur J Clin Pharmacol 27, 633–636 (1985). https://doi.org/10.1007/BF00547040

Download citation

Key words

  • lorcainide
  • lidocaine
  • placebo
  • antiarrhythmic drugs
  • ventricular premature beats
  • acute antiarrhythmic effect